# Royal Bank of Canada: financial statements, quarterly

RY · NYSE · CIK 1000275 · [Financials](/sectors/financials.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/ry.md) · [Financials](/companies/ry/financials.md) · [Filings](/companies/ry/filings.md) · [Insiders](/companies/ry/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ry/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2016-10-31) | period not labelled (2017-10-31) | FY2018 (2018-10-31) | FY2019 (2019-10-31) | FY2020 (2020-10-31) | FY2021 (2021-10-31) | FY2022 (2022-10-31) | FY2023 (2023-10-31) | FY2024 (2024-10-31) | FY2025 (2025-10-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [14.9](/filings/0001193125-18-335763.md) | [28.4](/filings/0001193125-19-305684.md) | [30.2](/filings/0001193125-20-307790.md) | [26.3](/filings/0001193125-21-344339.md) | [119](/filings/0001193125-22-294864.md) | [114](/filings/0001193125-23-285639.md) | [72.4](/filings/0001193125-24-270294.md) | [62.0](/filings/0001193125-25-305927.md) | [56.7](/filings/0001193125-25-305927.md) | [37.0](/filings/0001193125-25-305927.md) |
| Total assets | $bn | not reported | [1,213](/filings/0001193125-18-335763.md) | [1,335](/filings/0001193125-19-305684.md) | [1,429](/filings/0001193125-20-307790.md) | [1,625](/filings/0001193125-21-344339.md) | [1,706](/filings/0001193125-22-294864.md) | [1,917](/filings/0001193125-23-285639.md) | [2,007](/filings/0001193125-24-270294.md) | [2,172](/filings/0001193125-25-305927.md) | [2,325](/filings/0001193125-25-305927.md) |
| Total liabilities | $bn | not reported | [1,138](/filings/0001193125-18-335763.md) | [1,255](/filings/0001193125-19-305684.md) | [1,345](/filings/0001193125-20-307790.md) | [1,538](/filings/0001193125-21-344339.md) | [1,608](/filings/0001193125-22-294864.md) | [1,809](/filings/0001193125-23-285639.md) | [1,891](/filings/0001193125-24-270294.md) | [2,044](/filings/0001193125-25-305927.md) | [2,186](/filings/0001193125-25-305927.md) |
| Shareholders' equity | $bn | [71.6](/filings/0001193125-18-335763.md) | [73.8](/filings/0001193125-18-335763.md) | [79.9](/filings/0001193125-19-305684.md) | [83.5](/filings/0001193125-20-307790.md) | [86.7](/filings/0001193125-21-344339.md) | [98.7](/filings/0001193125-22-294864.md) | [108](/filings/0001193125-23-285639.md) | [115](/filings/0001193125-24-270294.md) | [127](/filings/0001193125-25-305927.md) | [139](/filings/0001193125-25-305927.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 1,400,635,338 at 2025-10-31, from the cover of the [40-F filed 2025-12-03](/filings/0001193125-25-305927.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.